Tracking artemisinin resistance in Plasmodium falciparum

The Lancet Infectious Diseases

Volumn 13, Issue 12, 2013, Pages 999-1000

  Sibley, Carol Hopkins ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; HOST FACTOR; MOLECULAR MARKER;

ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; CONTINUOUS CULTURE; DRUG HALF LIFE; DRUG RESPONSE; GENETIC MARKER; HUMAN; LETTER; MALARIA; MORBIDITY; MORTALITY; NONHUMAN; PARASITE CLEARANCE; PHENOTYPE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SURVIVAL;

ANTIMALARIALS; ARTEMISININS; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

EID: 84887621972     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70260-3     Document Type: Letter

References (13)

1. World malaria report 2012 WHO, (accessed Sept 2, 2013). http://www.who.int/malaria/publications/world_malaria_report_2012/en/.
2. Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Eng J Med 2009, 361:455-467.
3. Phyo AP, Nkhoma S, Stepniewska K, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 2012, 379:1960-1966.
4. Global plan for containment of artemisinin resistance WHO, (accessed Sept 2, 2013). http://www.who.int/malaria/publications/atoz/9789241500838/en/index.html.
5. Witkowski B, Amaratunga C, Khim N, et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect Dis 2013, published online Sept 11. http://dx.doi.org/10.1016/S1473-3099(13)70252-4.
6. White NJ, van Vugt M, Ezzet F Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine. Clin Pharmacokinet 1999, 37:105-125.
7. Amaratunga C, Sreng S, Suon S, et al. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis 2012, 12:851-858.
8. Anderson TJ, Nair S, Nkhoma S, et al. High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia. J Infect Dis 2010, 201:1326-1330.
9. Cheeseman IH, Miller BA, Nair S, et al. A major genome region underlying artemisinin resistance in malaria. Science 2012, 336:79-82.
10. Takala-Harrison S, Clark TG, Jacob CG, et al. Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc Natl Acad Sci USA 2013, 110:240-245.
11. Miotto O, Almagro-Garcia J, Manske M, et al. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet 2013, 45:648-655.
12. Noedl H, Wongsrichanalai C, Wernsdorfer W Malaria drug-sensitivity testing: new assays, new perspectives. Trends Parasitol 2003, 19:175-181.
13. Witkowski B, Khim N, Chim P, et al. Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia. Antimicrob Agents Chemother 2013, 57:914-923.